VanEck Pharmaceutical ETF (NASDAQ: PPH) stock price, news, charts, stock research, profile.
Open | $91.08 |
High | $91.17 |
52 Wk High | 93.44 |
AUM | 613.07M |
Volume | 72.31K |
Avg. Volume Daily | 147.39K |
Beta | 0.65 |
P/E Ratio | 25.51 |
Prev. Close | $90.96 |
Low | $90.14 |
52 Wk Low | 74.05 |
Mgmt Fee | 0.35% |
Market Cap | $197.81B |
Avg. Expense Ratio | 0.36% |
Shares Out | 6.09M |
P/B Ratio | 3.19 |
Dividend | $1.54 |
Ex-Div Date | Jul 1, 2024 |
Yield | 1.70% |
Div. Freq | Quarterly |
You can purchase shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) through any online brokerage.
There are no as such competitors for VanEck Pharmaceutical ETF.
There is no analysis for VanEck Pharmaceutical ETF.
There is no analysis for VanEck Pharmaceutical ETF to provide a consensus price target.
The stock price for VanEck Pharmaceutical ETF (NASDAQ: PPH) is $90.961 last updated July 2, 2024 at 4:05 PM EDT.
A quarterly cash dividend of 0.53 per share of Class A Common Stock. The quarterly cash dividend was payable on April 5, 2024 to stockholders of record on April 1, 2024.
VanEck Pharmaceutical ETF does not have any upcoming earnings scheduled.
There is no upcoming split for VanEck Pharmaceutical ETF.
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Large Cap Value |
Fund Inception | Dec 20, 2011 |
Managers | Griffin Driscoll Peter H. Liao |
Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
LLY | Eli Lilly & Co. | 11.7% |
CO | Novo Nordisk A/S ADR | 9.41% |
JNJ | Johnson & Johnson | 6.66% |
MRK | Merck & Company Inc. | 6.22% |
ABBV | Abbvie Inc Accenture P... | 6.06% |
LN | Astrazeneca Plc, ADR | 5.13% |
GVMXX | State Street Navigator... | 4.71% |
SM | Novartis Ag Sponsored ... | 4.70% |
COR | Cencora Inc | 4.60% |
MCK | Mckesson Corp. | 4.54% |